Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2013
03/21/2013US20130071380 Modulation of pilr to treat immune disorders
03/21/2013US20130071379 1b20 pcsk9 antagonists
03/21/2013US20130071353 Antiviral Compounds and Methods of Use Thereof
03/21/2013US20130071351 Combination therapy
03/21/2013US20130071350 Method and compositions for treatment of cancers
03/21/2013US20130071331 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
03/21/2013US20130071323 Therapies for hematologic malignancies
03/21/2013US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/21/2013CA2855955A1 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
03/21/2013CA2855781A1 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
03/21/2013CA2848611A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
03/21/2013CA2848487A1 Vaccine
03/21/2013CA2848484A1 Chimeric non-integrating lentiviral genomes as vaccines against hiv-1
03/21/2013CA2848403A1 Hyr1-derived compositions and methods of treatment using same
03/21/2013CA2846479A1 Method for measuring anti-wt1 antibody
03/21/2013CA2846354A1 Vaccine for protection against etec-induced diarrhea comprising dmlt
03/21/2013CA2846279A1 Method for increasing etec cs6 antigen presentation on cell surface and products obtainable thereof
03/20/2013EP2570484A1 Influenza virus-like particles (VLPS) comprising hemagglutinin
03/20/2013EP2570436A1 Use of neutralizing prolactin receptor antibodies in combined hormone therapy
03/20/2013EP2570435A1 Use of neutralizing prolactin receptor antibodies for the treatment of endometriosis and andenomyosis
03/20/2013EP2570433A1 Neutralizing human antibodies to anthrax toxin generated by recall technology
03/20/2013EP2570432A1 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
03/20/2013EP2570430A2 Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens
03/20/2013EP2570429A2 Peptide vaccines with Seq ID No: 48, 41, 44, 46 or 78 for cancers expressing tumor-associated antigens
03/20/2013EP2570428A2 Peptide vaccines with Seq ID No: 379 or 376 for cancers expressing tumor-associated antigens
03/20/2013EP2570427A1 Vaccine comprising a Ribosomal Protein Extract (RPE) and optionally a Th1-promoting adjuvant
03/20/2013EP2570423A1 Hepatitis C virus nucleic acid vaccine
03/20/2013EP2570137A2 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
03/20/2013EP2570136A2 Protein A compositions and methods of use
03/20/2013EP2570135A1 Vaccine
03/20/2013EP2569633A2 Compositions and methods of identifying tumor specific neoantigens
03/20/2013EP2569436A2 Recombinant hcmv and rhcmv vectors and uses thereof
03/20/2013EP2569416A1 Method of creating and sorting fused cells
03/20/2013EP2569336A1 Enhanced death receptor agonists
03/20/2013EP2569334A1 RECOMBINANTLY PRODUCED ANTIBODIES TARGETING ErbB SIGNALING MOLECULES AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE
03/20/2013EP2569267A1 Improved methods for preparing squalene
03/20/2013EP2569253A1 Extracorporeal devices and methods of treating complications of pregnancy
03/20/2013EP2569014A1 Treatment methods
03/20/2013EP2569013A2 Humanized and chimeric monoclonal antibodies to cd47
03/20/2013EP2569012A2 Anti-fgfr2 antibodies
03/20/2013EP2569011A1 Gep antibody and uses thereof
03/20/2013EP2569010A1 High concentration antibody formulations
03/20/2013EP2569009A1 Chimeric ospa genes, proteins, and methods of use thereof
03/20/2013EP2569008A1 Ospa chimeras and use thereof in vaccines
03/20/2013EP2569007A1 Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
03/20/2013EP2569006A2 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof
03/20/2013EP2568996A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
03/20/2013EP2568960A2 Liquid formulation of polypeptides containing an fc domain of an immunoglobulin
03/20/2013EP2495325A9 Dna vaccine against virus of yellow fever
03/20/2013EP2345670B1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
03/20/2013CN1571834B Cell therapy method for the treatment of tumors
03/20/2013CN102985530A Methods relating to an attenuated mycoplasma
03/20/2013CN102985441A Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
03/20/2013CN102985112A Pharmaceutical composition for treatment and prevention of herpesvirus infections
03/20/2013CN102985111A Gep antibody and uses thereof
03/20/2013CN102985110A Novel modulators
03/20/2013CN102985109A Homodimeric protein constructs
03/20/2013CN102985108A 活的减毒的细小病毒 Live attenuated parvovirus
03/20/2013CN102985107A Immunogenic influenza composition
03/20/2013CN102985106A Methods and compositions for treating Degos' disease
03/20/2013CN102985105A Nutritional Formulas Containing Synbiotics
03/20/2013CN102985103A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
03/20/2013CN102985100A Compositions and methods for treating COPD exacerbation
03/20/2013CN102985095A Immunostimulatory and vaccine compositions
03/20/2013CN102978713A Leukemia single-chain antibody library, as well as construction method and application thereof
03/20/2013CN102978219A Vibrio cross-protective antigen, and preparation and application thereof
03/20/2013CN102978168A gM-negative EHV-mutants without heterologous elements
03/20/2013CN102978167A Method for preparing nephropathogenic avian infectious bronchitis viruses and live vaccines by using cell lines
03/20/2013CN102978166A Method for preparing newcastle disease viruses and vaccines by using serial passage cells, and products thereof
03/20/2013CN102978126A Novel lactic acid bacterial strain, composition containing same and use thereof
03/20/2013CN102977219A Hypo- and hyper-acetylated meningococcal capsular saccharides
03/20/2013CN102977214A Recombinant protein HF2 used for methicillin-resistant staphylococcus aureus (MRSA) vaccine, and preparation method and application thereof
03/20/2013CN102977213A Monoclonal antibodies against NKG2A
03/20/2013CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production
03/20/2013CN102977209A Preparation method and application of multivalent yolk immunoglobulin for preventing and treating bouine mastitis
03/20/2013CN102977208A Preparation method, application and medicine composition and preparation of specific egg yolk immunoglobulin (IgY) and acinetobacter baumannii, as well as preparation and kit
03/20/2013CN102977194A Duck tembusu virus (DTMUV) E protein gene and application thereof
03/20/2013CN102973951A Koi herpesvirus ORF25 nucleic acid vaccine
03/20/2013CN102973950A PRAME and WT1 bivalent tumor DNA vaccine
03/20/2013CN102973947A Antibody-drug conjugates and methods
03/20/2013CN102973944A Preparation method of sugar-containing temperature-sensitive protein medicine carrier
03/20/2013CN102973939A IgY antibody preparation having mixed specificity for resistance to streptococcus mutans and streptococcus sobrinus, and preparation method and IgY total toothpaste
03/20/2013CN102973938A Avian infectious bronchitis antigen-antibody complex and preparation method thereof
03/20/2013CN102973937A Composition with skin beauty effect and oral administration cosmetic containing composition
03/20/2013CN102973936A Application of chitosan in avian vaccine composition preparation
03/20/2013CN102973935A Chicken subunit triple vaccine, as well as preparation and application thereof
03/20/2013CN102973934A Preparation method for Newcastle disease and avian influenza bi-combined inactivated vaccine
03/20/2013CN102973933A Bivalent vaccine for porcine reproductive and respiratory syndrome and classical swine fever prevention or treatment, and preparation method thereof
03/20/2013CN102973932A Trivalent inactivated vaccine of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and porcine pseudorabies virus and preparation method thereof
03/20/2013CN102973931A Production process for improving titer of swine fever live vaccine product
03/20/2013CN102973930A Chicken subunit bivalent vaccine, as well as preparation and application thereof
03/20/2013CN102973929A Multiple vaccination including serogroup C meningococcus
03/20/2013CN102973928A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response
03/20/2013CN102973506A Cationic liposome and preparation method thereof
03/20/2013CN102604993B Immunologic adjuvant-Helicobacter pylori antigen fused protein oral vaccine and preparation method thereof
03/20/2013CN102443571B Chicken-origin H9N2 avian influenza virus strain and application thereof
03/20/2013CN102399749B Stable replication and expression cell line of Chinese patient C gene type multiple drug resistant HBV (Hepatitis B Virus)
03/20/2013CN102277333B Monoclonal antibody resisting foot and mouth disease virus, epitope identified by monoclonal antibody, as well as application of monoclonal antibody
03/20/2013CN102220287B Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof
03/20/2013CN102168073B Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 1823